Meridian Bioscience's Q1 Revenues Rise 8 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Meridian Bioscience today reported an 8 percent hike in its fiscal first-quarter revenues helped along by its illumigene molecular diagnostic franchise.

For the three months ended Dec. 31, 2011, sales rose to $40.3 million, compared to $37.3 million in the year-ago period, but fell short of consensus analyst estimates of $43.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.